Aspire Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,677
Closed -$239K 80
2024
Q2
$239K Buy
1,677
+10
+0.6% +$1.43K 0.08% 65
2024
Q1
$214K Buy
+1,667
New +$214K 0.07% 76